Stay updated with breaking news from Impulse Dynamics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Implantable device trial to treat heart failure in higher ER population; Trial evaluates FDA-designated breakthrough therapy for patients who lack treatment options.
Impulse Dynamics Is Now Among the First US-based Manufacturers of Active Implantable Devices To Receive Certification
Impulse Dynamics Is Now Among the First US-based Manufacturers of Active Implantable Devices To Receive CertificationMARLTON, N.J., March 22, 2022 (GLOBE NEWSWIRE) -- Impulse Dynamics, a company dedicated
Trial Evaluates FDA-Designated Breakthrough Therapy for Patients Who Lack Treatment Options...
/PRNewswire/ -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise,...